Brief: Hester Biosciences Reports Higher Sept-Quarter Consol Net Profit

Hester Biosciences

28/10/2021 09:14

Oct 28 (Reuters) - Hester Biosciences Ltd  HEST.NS :
    * HESTER BIOSCIENCES LTD-SEPT-QUARTER CONSOL NET PROFIT
106.2
MILLION RUPEES VERSUS 66.8 MILLION RUPEES YEAR AGO
    * HESTER BIOSCIENCES LTD-SEPT-QUARTER CONSOL REVENUE FROM
OPERATIONS 626.6 MILLION RUPEES VERSUS 534.1 MILLION RUPEES YEAR
AGO
    * HESTER BIOSCIENCES - PROGRESSING WELL ON TIMELINE TO
MANUFACTURE
UPTO 7 MILLION DOSES/MONTH, EQUIVALENT DRUG SUBSTANCE FOR BHARAT
BIOTECH'S COVAXIN
    * HESTER BIOSCIENCES - WORKING TOWARDS INTRODUCING A PET
HEALTHCARE DIVISION

Source text for Eikon:  ID:nBSE87zM1x 
Further company coverage:  HEST.NS 

 ((reuters.briefs@thomsonreuters.com;))